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Inferior outcomes of autogenous infrainguinal
bypass in Hispanics: An analysis of ethnicity, graft
function, and limb salvage
William P. Robinson III, MD, Christopher D. Owens, MD, MSc, Louis L. Nguyen, MD, MBA, MPH,
Tze Tec Chong, MD, Michael S. Conte, MD, and Michael Belkin, MD, Boston, Mass
Introduction: Recent evidence suggests disparities exist among racial groups with peripheral arterial disease (PAD).
Hispanics (HI) are the fastest growing demographic in the United States, but little outcome data is available for this
population. Therefore, we undertook this study to compare the results of autogenous infrainguinal bypass grafting in HI
to Caucasians (CA) and African Americans (AA).
Methods: This was a comparative cohort study of prospectively collected registry data of infrainguinal bypass performed at
a tertiary center. Patient demographics and comorbidities, operative indications, bypass graft characteristics, and
postoperative courses were analyzed. Cumulative patency rates, limb salvage, mortality, and factors associated with these
outcomes were determined using Kaplan-Meier analysis and Cox proportional hazards models.
Results: From January 1, 1985, through December 31, 2007, 1646 consecutive patients (1408 CA, 57 HI, and 181 AA)
underwent 1646 autogenous infrainguinal reconstructions. HI and AA were younger and more often diabetic than CA
but HI had less chronic renal insufficiency (CRI) and dialysis-dependence than AA. AA, but not HI, more commonly
underwent bypass for critical limb ischemia (CLI) in comparison to CA (AA 90% vs CA 80%, P< .0001; HI 86%). HI and
AA bypass grafts had inflow and outflow distal to that in CA. Perioperative mortality (2.3%) and morbidity were similar
between groups. Five-year primary patency ( standard error [SE]) was significantly lower in HI compared to CA and
similar to that in AA (HI 54% 7% vs CA 69% 1%, P .02; AA 58% 4%). Cox proportional hazard modeling showed
high-risk conduit, age <65, CLI, female gender, and AA race were risk factors for failure of primary patency. Secondary
patency of HI grafts, unlike AA, was not different than that in CA. Five-year limb salvage ( SE) was significantly lower
in HI compared to CA and similar to that in AA (HI 80%  6% vs CA 91%  1%, P  .004; AA 83%  3%). Hispanic
ethnicity, CLI, high-risk conduit, age <65, CRI, female gender, and diabetes were significant predictors of limb loss.
Conclusion: Autogenous infrainguinal bypass surgery in HI is associated with primary patency and limb salvage inferior
to that of CA and similar to that of AA, despite HI rates of CLI equivalent to CA and HI comorbidities less severe than
AA. HI ethnicity was an independent predictor of limb loss. Our data provides evidence of outcome disparities in HI
treated aggressively for their PAD. Further investigation with regard to biologic and social factors is required to delineate
the reasons for these inferior outcomes in HI patients. ( J Vasc Surg 2009;49:1416-25.)The Hispanic (HI) population is the most rapidly
growing segment of the population within the United
States. It is estimated that the HI population, now at 45
million, will grow to 103 million by 2050 and comprise
25% of the US population.1 Although reports focused on
clinical treatment and outcomes in HI patients with
vascular disease have been historically sparse, outcome
disparities among HI with lower extremity occlusive
disease have received recent attention. Based primarily
on state discharge databases, HI have been found to be
more likely than Caucasians (CA) to undergo amputa-
tion and HI ethnicity has been identified as an indepen-
dent risk factor for amputation among patients with
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1416PAD.2-5 The reasons for this are unclear. HI have been
generally reported to have higher rates of diabetes than
CA, although this alone does not seem to account for the
higher incidence of amputation.4,6 In a sample of New
York and Florida hospital discharge databases, HI were
less frequently offered lower extremity revascularization
than CA despite higher rates of limb threatening isch-
emia.5
However, reports of the clinical presentation and
outcomes of HI patients who actually undergo revascu-
larization remain sparse. Furthermore, much of the ex-
isting data has been drawn from state or national dis-
charge databases which often suffer from a lack of
detailed clinical information, particularly regarding sur-
gical reconstruction, and a lack of standardized surgical
practice. Improved understanding of the risk factor pro-
files, severity of disease, and results of infrainguinal by-
pass is crucial to maximizing outcomes in HI. We previ-
ously reported that African American (AA) race is
associated with inferior primary patency and limb salvage
after autogenous infrainguinal bypass grafting compared
to CA.7 We undertook this present study to compare the
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patency, and limb salvage of autogenous infrainguinal
bypass grafting in HI relative to CA and AA.
METHODS
Patients. Patients undergoing treatment of vascular
disease at the Division of Vascular and Endovascular Sur-
gery at the Brigham and Women’s Hospital are prospec-
tively entered into a computerized vascular registry. The
registry collects data on patients with respect to demo-
graphics, comorbidities, indications for surgery, proce-
dural characteristics, perioperative morbidity and mor-
tality, medication use, graft patency, limb salvage (LS),
and survival. From this registry, a retrospective cohort
study was performed on all HI, AA, and CA patients who
had undergone autogenous infrainguinal bypass grafting
from January 1, 1985, to December 31, 2007. Hispanic
ethnicity and racial status were recorded as designated
by the patient at their hospital in-patient registration. The
presence of comorbidities was defined by notation in
the surgical or cardiology preoperative evaluation, except
chronic renal insufficiency (CRI) which was defined as a
preoperative creatinine2.0. To avoid double counting of
events in patients who may be predisposed to graft failure,
the first limb bypass was chosen as the index procedure in
patients who had undergone bilateral bypass. The index
bypass may have been either a primary operation or a
reoperative bypass done at our institution after a failed
bypass at another hospital.
Operative technique. The techniques of autoge-
nous infrainguinal arterial reconstruction that are prac-
ticed by this group have been previously published.8,9
The chosen inflow artery should be free of any significant
proximal disease, and the outflow artery should be the
least diseased vessel that provides the best distal perfu-
sion to the foot. The conduit of first choice was the
greater saphenous vein (GSV), which was used in either
the reversed (when there was no significant change in the
caliber of the vein) or the nonreversed (transposed or in
situ) configuration. In the absence of usable GSV, arm
veins (cephalic and basilic veins) and lesser saphenous
veins were used as either single-segment or composite
vein grafts. The criteria for an acceptable vein segment
were a minimum diameter of 3.5 mm, easy distensibility
with gentle irrigation, and absence of sclerotic or throm-
bosed areas. Vein segments that did not meet these
criteria were excised or repaired. We defined “high risk”
conduit as that which was anything other than single
segment greater saphenous vein and included spliced
vein, arm vein, or lesser saphenous vein. Completion
angiography was routinely performed in all cases. We
have also used intraoperative duplex scans in all cases
except when accurate graft assessment is made impossi-
ble by difficult anatomy. We image both anastomoses
and the length of the graft to look for evidence of vein
structural abnormalities or a 2.5-fold velocity increase
indicative of stenosis.Postoperative care and graft surveillance. After sur-
gery, patients were placed on aspirin or clopidogrel on the day
after operation and discharged on antiplatelet therapy unless
contraindicated or advised against due to risk of bleeding in
anticoagulated patients. Anticoagulation with heparin or
Coumadin (Bristol-Myers Squibb, New York, NY) was used
selectively if required for comorbid conditions or if the graft
was deemed high risk by the surgeon. Appropriate patients
are placed on beta-blockers and statins after their oper-
ation and maintained on them at discharge as advised by
cardiology. Graft surveillance with a duplex ultrasonog-
raphy scan was performed at 1 month and then at
3-month intervals for the first year and at 12-month
intervals thereafter. A recurrence of symptoms, a change
in the character of the graft or distal pulses, a decrease in
the ankle-brachial index greater than 0.1, or pulse vol-
ume recording waveforms was considered an indication
of possible graft stenosis prompting further evaluation.
Duplex scan criteria of impending graft failure included
decreased overall graft velocity (peak systolic velocity
25 cm/second in a normal-caliber graft) or a focal
increase in velocity (peak systolic velocity 300 cm/
second or an increase in peak systolic velocity in one
segment of the bypass greater than three times that of an
adjacent segment). Documented stenosis were evaluated
with arteriography and repaired unless the patient was
medically unfit for these procedures.
Outcomes. Major morbidity was defined as postoper-
ative myocardial infarction, pneumonia, acute renal failure,
cerebrovascular event, and deep venous thrombosis/
pulmonary embolism. Overall morbidity included wound
complications, postoperative arrhythmia, and miscella-
neous complications in addition to major morbidity. LS
was defined as freedom from transtibial or above-knee
amputation. Primary patency (PP), assisted primary pa-
tency (APP), and secondary patency (SP) rates were defined
in accordance with the suggested reporting standards of the
Society for Vascular Surgery/International Society for Car-
diovascular Surgery Ad Hoc Committee.10
Statistical analysis. Continuous variables were com-
pared by using analysis of variance (ANOVA) for multiple
groups and the t test between two groups. Categorical
variables were compared by a 3  2 2 for multiple groups
or Fisher’s exact test for two groups. Comparison between
two groups was only undertaken if the appropriate three-
group comparison showed statistically significant differ-
ences. Graft patency, LS, and patient survival rates were
analyzed with Kaplan-Meier curves and the log-rank test.
Multivariate analysis of demographic, medical, and proce-
dural factors affecting graft patency and LS was performed
with Cox proportional hazard models. Variables tested in
univariate analysis for potential inclusion in multivariate
regression models included the following: comorbidities
including age, gender, diabetes, smoking, hypertension,
coronary artery disease, congestive heart failure (CHF),
CRI, dialysis-dependence, or stroke; indications including
claudication, rest pain, and tissue loss; graft characteristics
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and the use of “high-risk” conduit. Variables associated
with loss of patency or amputation with a P value .20 on
univariate analysis were included in the multivariate regres-
sion model. An  value of .05, corresponding to P  .05
and 95% confidence intervals, was used as a criterion for
statistical significance. Loss to follow-up was defined as the
last patient visit or contact after 18 months. Statistical
computations were performed with SAS v9.1 (SAS Insti-
tute Inc, Cary, NC). Figs were generated with Intercooled
STATA 7 software (Stata Corp, College Station, Tex).
RESULTS
Demographics and comorbidities. From January 1,
1985, through December 31, 2007, 1646 patients under-
went autogenous infrainguinal reconstruction. Within this
group there were 57 HI (3.5% of study population), while
181 AA and 1408 CA within the same time period com-
prised the remainder of the cohort. HI (mean age 65.2
years; range, 34-88) and AA (mean age 64.7 years; range,
31-86) were significantly younger than CA (mean age 68.8
years; range, 19-96). AA, but not HI, were more likely to
be female than CA.
The HI comorbidity profile was unique relative to AA
and CA. HI, like AA, had a greater prevalence of diabetes
than CA. However, HI had rates of documented coronary
artery disease (CAD) and CHF equivalent to CA while AA
did not. Furthermore, HI had rates of CRI and dialysis-
dependence significantly lower than AA and similar to CA
(Table I).
Indication and bypass graft characteristics. The in-
dications for bypass were similar between HI and CA. The
rates of critical limb ischemia (HI 86% vs CA 80%,
P  .312) and tissue loss (HI 54% vs CA 47%, P  .223)
were not significantly different between HI and CA at the
time of bypass. By contrast, AA more commonly under-
went bypass for critical limb ischemia (CLI) in comparison
to CA (AA 91% vs CA 80%, P .0004) and AA had higher
rates of tissue loss than CA (AA 62% vs CA 47%, P 
Table I. Demographics and comorbidities
Hispanic n (%)
Age (median) 68a
Gender (male/female) 28/29 (49/51)
Diabetes 36 (63)a
Smoking 15 (26)
Hypertension 40 (70)
Coronary disease 28 (49)
CHF 6 (11)
CRI 8 (14)b
Dialysis-dependence 6 (11)b
Stroke 5 (9)
CHF, Congestive heart failure; CRI, chronic renal insufficiency.
aP  .05, Hispanic vs Caucasian.
bP  .05, Hispanic vs African American.
cP  .05, African American vs Caucasian..0001).Ninety percent of the bypasses in the AA cohort
compared with 81% in the HI cohort and 83% in the CA
cohort were primary operations. HI and AA more often
had inflow distal to the common femoral artery in com-
parison to CA (HI 49% vs CA 34%, P  .028; AA 43% vs
CA 34%, P  .0005). HI and AA also had a greater
proportion of infrapopliteal outflow in comparison to
CA (HI 74% vs CA 59%, P .0328; AA 72%, vs CA 59%,
P  .0001). There were no differences in the proportion
of tibioperoneal and pedal distal sites for distal anasto-
mosis. A single-segment saphenous vein was used as
conduit in the great majority of operations (HI 86%, AA
83%, and CA 85%, P  .793). The remainder were
performed with either autogenous composite vein, sin-
gle-segment arm vein, or lesser saphenous vein (HI 14%,
AA 17%, and CA 15%). Table II summarizes bypass graft
Table II. Indications and bypass graft characteristics
Hispanic
n (%)
African
American
n (%)
Caucasian
n (%)
Critical limb ischemia 49 (86) 163 (90)b 1119 (80)
Tissue loss 31 (54) 112 (62)b 663 (47)
Claudication 8 (14) 18 (10)b 289 (21)
Primary reconstructions 46 (81) 163 (90)b 1169 (83)
Inflow
Common femoral 29 (51)a 103 (57)b 924 (66)
Superficial/profunda
femoral 15 (26) 36 (20) 312 (22)
Popliteal 13 (23) 42 (23) 172 (12)
Outflow
Popliteal 15 (26)a 50 (28)b 574 (41)
Tibioperoneal 32 (56) 96 (53) 705 (50)
Pedal 10 (18) 35 (19) 129 (9)
Single segment GSV 49 (86) 150 (83) 1191 (85)
High risk conduit 8 (14) 31 (18) 217 (15)
GSV, Greater saphenous vein.
aP  .05, Hispanic vs Caucasian.
bP  .05, African American vs Caucasian.
frican American n (%) Caucasian n (%)
66c 70
82/99 (45/55)c 855/553 (61/39)
111 (61)c 649 (46)
53 (29)c 540 (38)
140 (77)c 887 (63)
66 (37)c 732 (52)
35 (19)c 129 (9)
58 (32)c 153 (11)
40 (22)c 79 (6)
34 (19)c 156 (11)Acharacteristics.
enou
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of antiplatelet (ASA and/or clopidogrel), Coumadin, beta-
blockers, and HMG-CoA reductase inhibitors (statins) on
admission were not significantly different between groups
(data not shown). HI were more likely than CA to be
discharged on a beta-blocker but there were no differences
in the use of antiplatelet, antithrombotic, or statin medica-
tions after bypass (Fig 1).
Thirty-day mortality was not different between groups
(HI 0%, AA 2.8%, and CA 2.3%, P  .468). Thirty-day
major morbidity (HI 5.3%, AA 4.4%, and CA 7.9%, P 
.462) and 30-day overall postoperative morbidity (HI
15.8%, AA 26.5%, and CA 21%, P  .252) were not
different between groups. Thirty-day graft failure for HI
was similar to that of CA while AA had an increased
incidence of early graft failure compared to CA (AA 11% vs
CA 5%, P  .012; HI 7%, Table III).
Duration of follow-up was as follows: HI - mean
44.5 months, median 25.7 months, range, 0.1-204.1
months; AA - mean 35.9 months, median 20.7 months,
range, 0.1-155.8 months; CA - mean 50 months, me-
dian 32.7 months, range, 0-266.5 months. There were
no significant differences between groups. The number
of patients lost to follow-up was not different between
groups (HI 10.5%, AA 8.8%, and CA 9%). The propor-
tion of patients who underwent one or more duplex
bypass graft scans during the first postoperative year was
not different between groups (HI 65%, AA 64%, and CA
Fig 1. Use of antithrombotics and medications for co
African Americans (AA), and Hispanics (HI) after autog58%, P  .195).Long-term results of bypass. The overall 5-year PP
( standard error [SE]) in HI was significantly lower than
that of CA and similar to that of AA (HI 54%  7% vs CA
69%  1%, P  .02; AA 58%  4%, Fig 2). The overall
5-year APP ( SE) was also lower in HI compared to CA
(HI 68%  7% vs CA 80%  1%, P  .027; AA 69%  4%,
Fig 3). However, the secondary patency rates were not
different between HI and CA while AA had inferior sec-
ondary patency compared to CA (AA 71% 4% vs CA 83%
 1%, P  .0002; HI 76%  6%, Fig 4). Five-year LS (
SE) in HI was significantly lower than that of CA and
similar to that of AA (HI 80%  6% vs CA 91%  1%;
P  .0004; AA 84%  3%, Fig 5). Five-year survival and
amputation-free survival were not different among groups.
Table III. Perioperative morbidity and mortality
Hispanic
n (%)
African American
n (%)
Caucasian
n (%)
Any morbiditya 9 (16) 48 (27) 335 (21)
Major morbidityb 3 (5) 10 (6) 109 (8)
30-day graft failure 4 (7) 19 (11)c 77 (5)
30-day mortality 0 (0) 5 (2.8) 33 (2.3)
aAny morbidity included wound complications, postoperative arrhythmia,
and miscellaneous complications in addition to major morbidity.
bMajor morbidity was defined as postoperative myocardial infarction, pneumo-
nia, acute renal failure, cerebrovascular accident, deep venous thrombosis/
pulmonary embolism.
cP  .012, African American vs Caucasian.
of cardiovascular risk factors among Caucasians (CA),
s infrainguinal bypass.ntrolFive-year outcomes are summarized in Table IV.
s show
ch gr
JOURNAL OF VASCULAR SURGERY
June 20091420 Robinson et alSignificant factors associated with failure of PP (Table V),
as well as APP and SP (Table VI), and LS (Table VII) were
determined using Cox proportional hazard modeling. His-
panic ethnicity was an independent predictor of limb loss
Fig 2. Primary patency of autogenous infrainguinal by
Hispanics (HI). The number at risk within each group i
Fig 3. Assisted primary patency of autogenous infrain
(AA), and Hispanics (HI). The number at risk within eaafter infrainguinal autogenous bypass.DISCUSSION
This study presents a novel characterization of HI
undergoing infrainguinal bypass. HI had a unique co-
rafts in Caucasians (CA), African Americans (AA), and
n in the table below the curve.
l bypass grafts in Caucasians (CA), African Americans
oup is shown in the table below the curve.pass gguinamorbidity profile significant for a younger age at presen-
s show
s show
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less CRI and dialysis-dependence than AA. HI, like
AA, presented with a preponderance of infrageniculate
Fig 4. Secondary patency of autogenous infrainguinal b
Hispanics (HI). The number at risk within each group i
Fig 5. Limb salvage after autogenous infrainguinal byp
Hispanics (HI). The number at risk within each group idisease but, unlike AA, did not present with increasedCLI in comparison to CA. HI had inferior primary
graft patency and limb salvage in comparison to CA.
Hispanic ethnicity was an independent predictor of limb
grafts in Caucasians (CA), African Americans (AA), and
n in the table below the curve.
afting in Caucasians (CA), African Americans (AA), and
n in the table below the curve.ypassass grloss.
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disproportionally impacts HI. While administrative dis-
charge data provide evidence of outcome disparities in HI
with peripheral arterial occlusive disease, there is a paucity
of data regarding the clinical presentation, bypass graft
characteristics, and bypass results to guide the vascular
surgeon in counseling and treating this population. To our
knowledge, there have been only two reports which specif-
ically addressed the results of bypass in the HI popula-
tion.11,12 These both reported results of infrapopliteal by-
pass only and one studied an entirely diabetic population.11
We therefore examined our experience in the broader
group of HI undergoing autogenous infrainguinal bypass
Table IV. Overall 5-year outcomes ( SE)b
Hispanic
n (%)
African American
n (%)
Caucasian
n (%)
Primary patency 54  7a 58  4b 69  1
Assisted primary
patency 68  7a 69  4b 80  1
Secondary patency 76  6 71  4b 83  1
Limb salvage 80  6a 84  3b 91  1
Survival 64  7 58  4 61  1
Amputation-free
survival 52  8 54  4 57  1
SE, Standard error.
aP  .05, Hispanic vs Caucasian.
bP  .05, African American vs Caucasian.
Table V. Predictors of loss of primary patency
Variable Hazard ratio (95% CI) P value
High-risk conduit 1.98 (1.6-2.45) .0001
Critical limb ischemia 1.47 (1.13-1.90) .0004
Hispanic 1.47 (0.97-2.24) .067
Age 65 1.36 (1.13-1.64) .035
African American 1.33 (1.02-1.73) .035
Female gender 1.24 (1.03-1.49) .023
Distal outflow 1.09 (0.94-1.26) .27
CI, Confidence interval.
Table VI. Predictors of loss of assisted primary patencya
Variable Hazard ratio (95% CI) P value
High-risk conduit 1.94 (1.5-2.52) .0001
Critical limb ischemia 1.74 (1.25-2.44) .0012
Hispanic 1.63 (0.99-2.68) .055
Smoking 1.49 (1.18-1.88) .0007
Age 65 1.48 (1.17-1.87) .001
African American 1.47 (1.07-2.01) .016
Female gender 1.33 (1.06-1.67) .013
Distal outflow 1.25 (1.02-1.54) .033
Distal inflow 0.98 (0.83-1.17) .839
CI, Confidence interval.
aThe significant predictors for loss of secondary patency were the same as
those for loss of assisted primary patency though the hazard ratios were not
identical and are not reported here.and compared it to our experience in CA and AA patients.The comorbidity profile of HI was distinct from that of
CA and AA. The younger age and increased diabetes in HI
are consistent with the comorbidity profiles reported forHI
with peripheral arterial disease (PAD) in larger population-
based studies.5,13,14 Further study will be necessary to
clarify the implications younger age and diabetes have on
the virulence of PAD seen in HI patients. A key difference
betweenHI and AA in our study was the significantly lower
rate of CRI and dialysis-dependence in HI, a finding con-
sistent with previous reports of the prevalence of CRI in
these populations.15
Importantly, in our series, HI undergoing bypass did
not have higher rates of critical limb ischemia or tissue loss
in comparison to CA at the time of bypass. This stands in
contrast to AA whose indication for bypass was more
commonly CLI and who presented more often with tissue
loss. This observation is similar to results of the series of
infrapopliteal bypass by Rowe et al,12 but differs from
population-based studies in which a larger proportion of
HI presented with limb threat.5 As a tertiary referral center,
our HI population may present earlier than HI in a center
which serves a more indigent population. At least in our
population, increased limb loss cannot be attributed to
increased severity of ischemia at presentation.
To our knowledge, there is no previous information
about the distribution or anatomic severity of PAD inHI at
the time of revascularization. In our series, bypass grafts
were reflective of a distal pattern of occlusive disease in HI
similar to that in AA, in whom the predilection of arterial
disease to the infrageniculate level is well described.16 The
difficulty, both real and perceived, in reconstructing infra-
geniculate disease may contribute to the inferior results
reported in HI with PAD. Lavery et al6 report that
Mexican-American diabetics were four times as likely to
have had a failed bypass or to be categorized as “not a
bypass candidate” in comparison to non-Hispanic whites.
Previous studies have documented the efficacy of distal
origin and distal target bypass.17,18 Continued excellence
in infrageniculate revascularization should be emphasized
to effectively treat both the AA and HI populations.
The 5-year PP and APP were significantly worse in the
Table VII. Predictors of limb loss
Variable Hazard ratio (95% CI) P value
Critical limb ischemia 4.22 (2.02-8.81) .0001
Hispanic 1.87 (1.0-3.49) .0499
High-risk conduit 1.81 (1.27-2.6) .0012
Age 65 1.55 (1.12-2.13) .008
Chronic renal
insufficiency 1.54 (1.02-2.34) .041
African American 1.45 (0.97-2.17) .0736
Female gender 1.38 (1.01-1.89) .045
Diabetes mellitus 1.35 (0.96-1.88) .045
Distal outflow 1.33 (0.99-1.77) .057
Distal inflow 1.18 (0.94-1.48) .157
CI, Confidence interval.HI cohort compared to the CA cohort. This was not due to
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between groups. Furthermore, conduit was not of inferior
quality. Bypass grafts were just as frequently primary recon-
structions performed with single-segment saphenous veins
in HI as in CA. Loss of PP in HI is markedly inferior to that
of CA in the period up to about 24 months. Thrombec-
tomy and revision after graft failure were able to maintain a
secondary graft patency in HI not statistically different
from that of CA or AA. On multivariate analysis, high-risk
vein conduit, the presence of critical limb ischemia, young
age, female gender, and AA race were significant predictors
of primary graft failure. Though associated with a hazard
ratio for graft failure of almost 1.5, HI ethnicity did not
meet statistical significance as a predictor of failure. Our
analysis suggests that the inferior PP and APP in the HI
cohort is related to their young age at presentation as HI
were not significantly different from CA or AA on those
other factors which predicted failure of patency. Further
investigation into the impact and potential interplay of age,
gender, and additional comorbidities in HI will help iden-
tify those at high risk for graft failure.
The most significant result from this analysis was that
the 5-year limb salvage after bypass in HI was markedly
worse than that of CA and similar to that of AA. Multi-
variate analysis identified HI ethnicity as an independent
predictor of limb loss. To our knowledge, this is the first
study identifying HI ethnicity as an independent predic-
tor of limb loss after infrainguinal revascularization.
There was a trend toward inferior outcomes after bypass
in HI compared to CA in the study by Rowe et al.12
Toursarkissian et al11 combined AA and CA into a
“non-Hispanic” group which had outcomes equivalent
to that of HI. Given our results, we are not surprised that
their outcomes in HI were equivalent to that of AA and
CA combined.
Our data provides some insight into the reasons for
increased limb loss in both HI and AA. Our analysis
corroborates previous studies that have reported the
negative impact of critical limb ischemia, young age,
female gender, CRI, and diabetes on limb salvage.4,19-21
The limb loss seen in AA is accounted for by these
associated comorbidities. On the other hand, HI limb
salvage was notably low despite the fact that HI rates of
CLI were equivalent to CA and HI had a comorbidity
profile less severe than AA, including less CRI. Further-
more, HI had secondary graft patency equivalent to that
of CA. The possibility exists that this study is underpow-
ered to detect a true difference in secondary patency that
might contribute to limb loss in HI. Nevertheless, the
data suggests that additional factors not available in our
data must be implicated in the high risk of amputation
among HI despite our aggressive stance toward revascu-
larization and graft maintenance.
Inferior outcomes in HI and AAmight involve a variety
of sociologic and biologic mechanisms. The lower socio-
economic status ofHI and AA and associated poor access to
health care, as well as unhealthy behaviors and lifestyles,
could have significantly impacted these populations.22-24Language and cultural barriers as well as provider bias may
also inhibit effective physician-patient communication and
influence treatment decisions.25-28 Overt provider bias is
unlikely to have impacted this study because it was per-
formed by an established group of vascular surgeons with a
uniform, aggressive policy of limb salvage. Graft surveillance
and use of medications were equivalent between groups.
However, postoperative care is uniform only insofar as we
can assess it with this study design. Further investigation
with additional data would be required to determine if
socioeconomic and cultural disparities could have influ-
enced the preoperative care and postoperative courses of
HI and AA.
Biologic mechanisms not routinely measured or ac-
counted for in this study may also contribute to inferior
outcomes in HI and AA. Given the existing evidence in HI
and AA, metabolic syndrome and inflammation are excel-
lent candidates for future investigation. Recent studies have
elaborated the strong association between metabolic syn-
drome, insulin resistance, inflammation, and severity and
progression of PAD.29-34 HI and AA have high rates of
obesity, metabolic syndrome, and inflammation.35-39 In
addition, evidence shows that metabolic syndrome and
vascular inflammation are intricately related, including
within specific HI populations.30,35,40 Furthermore, in-
flammation has been strongly correlated withmajor adverse
events after infrainguinal bypass including graft occlusion,
the need for graft revision, and amputation.19 While our
data does not address these mechanisms at this time, met-
abolic syndrome and inflammation in HI will be a focus of
our future investigation.
The primary limitation of this study is the small sample
size of the HI cohort. This reflects the demographics of our
tertiary referral center and thus the results may not be
generalizable to all other populations. Furthermore, there
is inherent heterogeneity in the designation “Hispanic.” As
an ethnicity, the term “Hispanic” encompasses a variety of
racial, geographic, genetic, and cultural backgrounds. This
makes it difficult to apply conclusions to all HI patients. All
investigations of disparities and comparison of outcomes
between ethnic groups suffer from this inherent limitation.
In this study, ethnicity and race were recorded as desig-
nated by the patient on hospital admission. We believe this
to be the most accurate and consistent method of identify-
ing this group of patients.
CONCLUSION
Autogenous infrainguinal bypass in HI patients is asso-
ciated with PP and LS inferior to that in CA and similar to
that in AA, despite HI rates of CLI equivalent to CA and
HI comorbidities less severe than AAs. Hispanic ethnicity is
an independent risk factor for limb loss after autogenous
infrainguinal bypass. Disparities in outcome thus persist in
HI treated aggressively for PAD. Further investigation into
the reasons for graft failure and limb loss, both sociologic
and biologic, is warranted in order to improve results of
treatment for PAD in this growing high-risk population.
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